Crossmark

Processed plant-based meat-supplemented diet versus red meat-based supplemented diet randomized cross-over trial Finding Optimal Oral Diet-1 (FOOD-1) trial

Crossref DOI link: https://doi.org/10.1038/s41598-026-41165-3

Published Online: 2026-03-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ferreira, João Pedro

Marques, Pedro

Zhang, Guang

Possik, Elite

Mavrakanas, Thomas A.

Tsoukas, Michael A.

Sharma, Abhinav
License Information

Text and Data Mining valid from 2026-03-11

Accepted Manuscript valid from 2026-03-11
More Information

Article History

Received: 7 September 2025

Accepted: 18 February 2026

First Online: 11 March 2026

Declarations

:

: JPF has received research support from Boehringer-Ingelheim, AstraZeneca and Novartis, through his institution, the University of Porto. PM has received salary support from an educational grant from Janssen. AS has received support from the Fonds de Recherche Santé Quebec (FRSQ) Junior 1 clinician scholars’ program, Canadian Institute of Health Research (Grant #175095), Roche Diagnostics, Boehringer-Ingelheim, Novartis, Janssen, Novo-Nordisk, Servier, AstraZeneca, and Takeda. TAM received speaker honoraria from Daiichi Sankyo, BMS Canada, Janssen, Astra Zeneca, and Pfizer and has served on advisory boards for Boehringer Ingelheim, Bayer, GSK, and Servier outside the submitted work. He has also received an unrestricted research grant from Astra Zeneca. He is supported by an FRQS Clinician Scholar Award. MAT reports personal fees from Boehringer-Ingelheim, AstraZeneca, Janssen, Novo-Nordisk, and Eli Lilly, outside the submitted work. The reminder authors report not having relevant conflicts of interest regarding the content of this manuscript.

Document is current

Any future updates will be listed below